what are the long-term effects of glp-1 long term glp 1 use Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients What are experts learning about

And full results in clinical trials are measured at 68-72 weeks, not 68-72 days

The real challenge ahead will be aligning supply capabilities with this rapid demand shift

Therefore, these drugs should not be given to people with uncontrolled T2D, polyuria, and polydipsia or people who develop severe symptoms that predispose to volume depletion (for example vomiting)

PIONEER 5 The PIONEER 5 study enrolled patients with T2DM and moderate renal impairment (estimated glomerular filtration rate [eGFR] of 3059 mL/ min/1.73 m 2 ) to examine the efficacy and safety of oral semaglutide in patients with compromised kidney function

Int J Ophthalmol